Aaron Johnsen
Dec 7, 2016
Featured

CRISPR heavyweights battle in US patent court

On 6 December, attorneys for the university laid out its claim to the gene-editing tool called CRISPR–Cas9 during a hearing at the US Patent and Trademark Office (USPTO) — and drew intense, sometimes sceptical, questioning from the three judges who will decide the fate of patents that could be worth billions of dollars.

http://www.nature.com/news/crispr-heavyweights-battle-in-us-patent-court-1.21101